MeSH D000130 - achondroplasia
Favorite
Competitive Landscape
Events Timeline
Commercial
Clinical Trials
Competitive landscape
Events Timeline
Commercial
Company Name | Drug Name | Trade Name | Patent Expires | Approval Date | Revenue | Period |
|---|---|---|---|---|---|---|
| BioMarin Pharmaceutical | Vosoritide | Voxzogo | 2030-05-20 | 2021-11-19 | $534.934 M | Q2/23-Q1/24 |
Clinical Trials
Historical Success Rate
Phase 1
100%1/1
Phase 2
33%1/3
Phase 3
100%3/3
Approved: 2Overall Success rate: 33%
All Clinical Trials
Therapeutic Areas:
All
Classification:
All
Approval:
All
Status:
All
Phases:
All
Company name | Phase 1 | Phase 2 | Phase 3 | Phase 4 | Drug Name |
|---|---|---|---|---|---|
© 2020-2024 Collaborative Drug Discovery Inc. (CDD) | Terms of Use